We found the APOE ε4 allele to significantly impact the insoluble FLNA levels in AD when comparing participants without AD, ε4 noncarriers AD and ε4 carriers AD participants (F = 7.348(54), p = 0.002, Figure 5A). Here, APOE is linked to Alzheimer disease.